ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

DNA methylation-based patterns for early diagnostic prediction and prognostic evaluation in colorectal cancer patients with high tumor mutation burden

Huang, Hao; Cao, Weifan; Long, Zhiping; Kuang, Lei; Li, Xi; Feng, Yifei; Wu, Yuying; Zhao, Yang; Chen, Yinggang; Sun, Peng; Peng, Panxin; Zhang, Jinli; Yuan, Lijun; Li, Tianze; Hu, Huifang; Li, Gairui; Yang, Longkun; Zhang, Xing; Hu, Fulan*; Sun, Xizhuo*; Hu, Dongsheng*哈尔滨医科大学; 中国医学科学院; 中国医学科学院北京协和医院
Frontiers in Oncology2023-1-13DOI: 10.3389/fonc.2022.1030335
2被引7阅读
引用收藏
分享

摘要

BackgroundImmune checkpoint inhibitor (ICI) therapy has proven to be a promising treatment for colorectal cancer (CRC). We aim to investigate the relationship between DNA methylation and tumor mutation burden (TMB) by integrating genomic and epigenetic profiles to precisely identify clinical benefit populations and to evaluate the effect of ICI therapy. MethodsA total of 536 CRC tissues from the Cancer Genome Atlas (TCGA) with mutation data were collected and subjected to calculate TMB. 80 CRC patients with high TMB and paired normal tissues were selected as training sets and developed the diagnostic and prognostic methylation models, respectively. In the validation set, the diagnostic model was validated in our in-house 47 CRC tissues and 122 CRC tissues from the Gene Expression Omnibus (GEO) datasets, respectively. And a total of 38 CRC tissues with high TMB from the COLONOMICS dataset verified the prognostic model. ResultsA positive correlation between differential methylation positions and TMB level was observed in TCGA CRC cohort (r=0.45). The diagnostic score that consisted of methylation levels of four genes (ADHFE1, DOK6, GPR75, and MAP3K14-AS1) showed high diagnostic performance in the discovery (AUC=1.000) and two independent validation (AUC=0.946, AUC=0.857) datasets. Additionally, these four genes showed significant positive correlations with NK cells. The prognostic score containing three genes (POU3F3, SYN2, and TMEM178A) had significantly poorer survival in the high-risk TMB samples than those in the low-risk TMB samples (P=0.016). CRC patients with low-risk scores combined with TMB levels represent a favorable survival. ConclusionsBy integrating analyses of methylation and mutation data, it is suggested that DNA methylation patterns combined with TMB serve as a novel potential biomarker for early screening in more high-TMB populations and for evaluating the prognostic effect of CRC patients with ICI therapy.

学科与关键词

关键词
TMBDNA methylationcolorectal cancerimmunotherapyTCGA
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2023-01-13
卷期
第 12 卷
页码
1030335
DOI
10.3389/fonc.2022.1030335
成果收录
SCIE
资助标注
Shenzhen Key Medical Discipline Construction Fund [SZXK062]; Natural Science Foundation of China [81302483]; Science and Technology Development Foundation of Shenzhen [JCYJ20190808111817192, JCYJ20210324093807020]; Scientific Research Initiation foundation for young teachers of Shenzhen University [2019123, QNJS0160]

作者

  • H

    Huang, Hao (第一作者)

    shenzhen univ

  • C

    Cao, Weifan

    shenzhen univ

查看全部 21 位作者收起作者
  • L

    Long, Zhiping

    harbin med univ

  • K

    Kuang, Lei

    shenzhen univ

  • L

    Li, Xi

    shenzhen univ

  • F

    Feng, Yifei

    shenzhen univ

  • W

    Wu, Yuying

    shenzhen univ

  • Z

    Zhao, Yang

    shenzhen univ

  • C

    Chen, Yinggang

    chinese acad med sci · peking union med coll

  • S

    Sun, Peng

    chinese acad med sci · peking union med coll

  • P

    Peng, Panxin

    chinese acad med sci · peking union med coll

  • Z

    Zhang, Jinli

    shenzhen univ

  • Y

    Yuan, Lijun

    shenzhen univ

  • L

    Li, Tianze

    shenzhen univ

  • H

    Hu, Huifang

    shenzhen univ

  • L

    Li, Gairui

    shenzhen nanshan ctr chron dis control

  • Y

    Yang, Longkun

    fujian med univ

  • Z

    Zhang, Xing

    fujian med univ

  • H

    Hu, Fulan (通讯)

    shenzhen univ

  • S

    Sun, Xizhuo (通讯)

    shenzhen univ

  • H

    Hu, Dongsheng (通讯)

    shenzhen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417